Gerald L. Andriole Jr., MD, presented “MicroUltrasound of the Prostate” during the 44th Annual Ralph E. Hopkins Urology Seminar on February 5, 2025, in Jackson Hole, Wyoming.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Andriole, Gerald L. “MicroUltrasound of the Prostate.” February 5, 2025. Accessed Mar 2025. https://grandroundsinurology.com/microultrasound-of-the-prostate/
MicroUltrasound of the Prostate – Summary
Gerald L. Andriole, Jr., MD, discusses the evolving role of micro-ultrasound in prostate cancer detection. In this 11-minute presentation, Dr. Andriole highlights the potential of micro-ultrasound to refine diagnostic accuracy and improve patient outcomes.
Dr. Andriole emphasizes that this technology surpasses conventional transrectal ultrasound in resolution, allowing for detailed visualization of prostate tissue and enabling real-time targeted biopsies. He explains the PRI-MUS classification, which parallels the PIRADS system for MRI, helping to stratify cancer risk based on ultrasound findings. He shares striking imaging examples, illustrating micro-ultrasound’s ability to detect biopsy tracks and fine tissue structures, underscoring its precision.
Dr. Andriole discusses emerging research, including a large multi-institutional study showing comparable or superior sensitivity of micro-ultrasound compared to MRI. He teases upcoming groundbreaking data from an EAU presentation and a forthcoming peer-reviewed publication, suggesting it may redefine biopsy protocols. He emphasizes that micro-ultrasound integrates seamlessly with current techniques, offering flexibility for transrectal or transperineal approaches.
About The 44th Annual Ralph E. Hopkins Urology Seminar:
The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 44th iteration of the meeting took place from February 5th to February 8th, 2025, in Jackson Hole, Wyoming.
For further educational activities from this conference, visit our collection page.
ABOUT THE AUTHOR
Gerald L. Andriole, Jr., MD, is the global Chief Medical Officer at Prostatype Genomics. He previously was Professor and Director of Urology in the National Capital Region at the Brady Urologic Institute at Johns Hopkins University. He also formerly served as the Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish Hospital, the Siteman Cancer Center, and Washington University School of Medicine in St. Louis, Missouri.
Dr. Andriole received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He trained in surgery at Strong Memorial Hospital and the University of Rochester, and completed his Urology Residency at Brigham and Women’s Hospital and Harvard Medical School. Subsequently, he was a Fellow in Urologic Oncology at the National Cancer Institute in Bethesda, Maryland. Dr. Andriole has over 40 years of consistent contributions in the areas of prostate cancer screening and prevention research as well as BPH. He has contributed to over 450 peer-reviewed publications. He chaired the Prostate Committee of NCI’s PLCO Cancer Screening Trial, the Steering Committee of the international REDUCE International Prostate Cancer Prevention Trial and the Prostate Committee of the SUO Clinical Trials Consortium. He is a member of the American Urological Association, the Academy of Master Surgical Educators of the American College of Surgeons, the American Surgical Association, the American Association of Genitourinary Surgeons, and the Clinical Society of Genitourinary Surgeons, among other societies.
He has received the Outstanding Achievement Award from the Urologic Oncology Branch of NCI, the Distinguished Clinician Award from Washington University, the Alumni Award from Jefferson Medical College, and the Williams Award for Prostate Cancer Research Excellence from the AUA Urology Care Foundation, among others.
